Good news! The price of Splenda may soon be going down! The primary patent held for Splenda by Tate & Lyle has already expired. They hold numerous other patents but this still opens the door to competition. Other companies can now create Splenda as well, and will soon bring it to market under different brand names (but it will be virtually the same thing just like a generic drug). This competition will encourage price to drop which is good news for everyone (except maybe Tate & Lyle).
Despite the questionable announcement of a “shortage of Splenda” which was probably bogus (I don’t have facts, but really, a shortage? Gimme a break), now the news that the patents are expired. Coincidence? I think not.
Splenda is considered far safer than aspartame and many companies are moving to use it. Seven-up has just announced they will be brining a diet 7-Up to market sweetened with Splenda.
Hopefully the day will come with the FDA will recognize that Stevia is even better being a plant (not a chemical process), and will let it be grown and sold as a sweetener. Why they do not now is beyond me. It’s as if they declared sugar cane a drug. Sugar cane is a plant, so is Stevia. Why is one okay, and one not? Ask big business.
